Implantica advances in Sweden with its medical device RefluxStop™
Implantica AG (publ) today announces that RefluxStop™ will start selling in Sweden with reimbursement by public healthcare.Implantica will now focus on scaling up its sales force in Scandinavia as it introduces RefluxStop™ to the leading anti-reflux surgeons and centers in Sweden, which will be a second home market due to the company’s significant ties to Sweden and its large Scandinavian investor base. Surgical training will commence initially via webinar and will include representatives from Germany and Switzerland. “We are very pleased to be able to sell RefluxStop™ on a reimbursed